-omics

AgBiome uses its proprietary Genesis platform to collect, isolate and analyze microbes for use in the discovery and development of biologicals and traits for protecting crops and is researching probiotic products to address swine gut health challenges.

Atlas Regeneration develops bioinformatics platforms for drug discovery related to regenerative medicine and stem cell research. Atlas Regeneration also screens drugs in silico for drug repositioning.

Attagene has developed a pathway profiling technology to evaluate the impact of pharmaceuticals and environmental chemicals on over 100 transcription factors and 48 nuclear receptors.

BioGenomics provides pharmacogenomic testing to inform prevention, diagnosis and treatment of various diseases.

bioMONTR provides a broad range of CLIA-certified high-complexity laboratory testing, including assay/IVD protocol development, validation design, performance evaluation testing, drug trials and collaborative studies and regulatory/quality control.

BioSkryb's SkrybAmp technology is a new DNA amplification technology powered by Primary Template Directed Amplification (PTA).

Cancer Genetics offers diagnostic products and services that enable precision medicine in the field of oncology. This site performs clinical pharmacogenomic testing and provides biorepository services under federally-designated clinical lab standards.

The Charlotte Research Institute provides limited laboratory and office space to partner firms that are engaged in collaboration with its researchers.

Cohesion Phenomics is a CLIA-certified molecular diagnostic laboratory. Cohesion Phenomics also develops DNA sequencing tests for complex and single gene disorders within specific clinical areas such as cardiovascular disease.

Creative Scientist offers rapid in vitro ADME-TOX testing including 96-well permeability assays using MDCK cells. Creative Scientist also provides novel functional assays for cytotoxic T-cells.

The Center for Genomic & Computational Biology (GCB) is an interdisciplinary center where faculty across Duke’s campus collaborate to study complex problems in genomic and computational biology, train researchers and develop genomic technologies.

Eurofins Craft Technologies provides analytical and method development services to measure nutritional components in blood, tissues, dietary supplements, food and animal feed.

GeneCentric Therapeutics develops molecular diagnostic assays to enable oncologists and their patients to make informed, individualized treatment decisions.

Glycan Therapeutics offers synthetic carbohydrates of various lengths to aid researchers investigating multiple therapeutic areas. Glycan also offers custom synthesis and array analysis of heparan and chondroitin sulfate oligosaccharides derivatives.

Inanovate has developed a patented blood analysis system (the Bio-ID) for diagnostic tests. The first application of the Bio-ID is a new blood test to detect breast cancer recurrence at a stage when it may still be cured.

IngateyGen (IGG) is developing a hypoallergenic peanut plant in an effort to eradicate severe and fatal allergic reactions caused by peanuts. IGG also provides organic and food testing services.

Integrated Omics provides strategic consulting, study design and data analysis services for companies working in the genomics, proteomics and metabolomics sectors.

KlearOptix develops advanced contact lens technology, including bandage lenses for healing, intraocular lenses for cataract surgery and new materials for soft, rigid and hybrid contact lenses.

Laudiss Labs uses advanced proprietary platform technologies for quantitative DNA and protein testing of GMOs, foodborne pathogens and mycotoxins in food and feed.

LemnaTec offers phenotyping solutions for quantitative root, shoot, seed and pest evaluation in plant biology research and agricultural product development.

Locus Biosciences is developing CRISPR-engineered bacteriophage (“crPhage”) products that kill target bacteria by irreversibly destroying their DNA while leaving the many species of beneficial bacteria in the body unharmed.

Metabolon is advancing the science of metabolomics for the clinic and life sciences research. Its technology and data are used for biomarker discovery, diagnostic test development, and genomics and population health initiatives.

NanoMedica provides ultrasensitive detection reagents and nanotechnology-based drug discovery services and tools to biopharmaceutical companies as well as DNA and RNA sequencing services.

The UNC Nutrition Research Institute conducts innovative basic and translational science studying how individual differences in requirements and responses to diet affect our individual nutritional needs.

Phytobiotics produces and distributes botanical and phytogenic supplements and flavors for plant and animal nutrition. Additionally, Phytobiotics provides consultative services focused on intestinal health and increased nutrient bioavailability.

Q² Solutions is a global clinical trial laboratory services leader that provides secure, enterprise-wide biospecimen and consent management solutions.

Sciome develops bioinformatics, chemoinformatics and text mining solutions for data analytics, data management and visualization via consulting services and products.

Shoaf Scientific Consultants provides research and development services in plant redox bioenergetics, antimicrobial surface technologies and molecular photochemical studies in singlet oxygen and superoxide-free radical anion as applied to aging.

Symberix is developing microbiome-targeted, small-molecule drugs to treat serious lower gastrointestinal (GI) diseases as well as mitigate the lower GI side effects associated with various cancer, pain and immunosuppressive therapies.

TIRF Labs develops, manufactures and markets a broad range of products based on total internal reflection fluorescence (TIRF), including add-on TIRF accessories for microscopy and spectroscopy, TIRF biosensors and fluorescence illuminators.

Vascular BioSciences is a biopharmaceutical company developing solutions for difficult-to-treat cardiovascular and inflammatory diseases.

Xenobiotic Detection Systems offers patented bioassays to facilitate assessment of environmental and human health risks.